Ontology highlight
ABSTRACT: Background
Recently, mesenchymal stem cells therapy has been performed in dogs, although the outcome is not always favorable.Objectives
To investigate the therapeutic efficacy of mesenchymal stem cells (MSCs) using dog leukocyte antigen (DLA) matching between the donor and recipient in vitro.Methods
Canine adipose-derived MSCs (cA-MSCs) isolated from the subcutaneous tissue of Dog 1 underwent characterization. For major DLA genotyping (DQA1, DQB1, and DRB1), peripheral blood mononuclear cells (PBMCs) from two dogs (Dogs 1 and 2) were analyzed by direct sequencing of polymerase chain reaction (PCR) products. The cA-MSCs were co-cultured at a 1:10 ratio with activated PBMCs (DLA matching or mismatching) for 3 days and analyzed for immunosuppressive (IDO,
SUBMITTER: Wi H
PROVIDER: S-EPMC8460457 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature